Sleep. We all want it. Melatonin is supposed to give it to you. It tricks the brain into thinking it’s late, slowing things down in the hypothalamus so you can actually rest. Simple. But a new look at the data suggests it does something else entirely.
It hurts less.
A team from the University of Sydney, led by Kangchao Wu, sifted through 23 previous clinical trials. They were looking for a signal in the noise about chronic musculoskeletal pain —that nagging ache in muscles, bones, and joints. The result was clearer than they expected.
The supplement works.
Across 2,028 people in countries scattered all over the globe, melatonin reduced pain. On a 0 to 100 scale, pain dropped by roughly 9 points. It didn’t cure them. It didn’t make the world bright. But for conditions like osteoporosis, fibromyalgia, and lower back pain, it mattered. In some cases, the relief was on par with opioids or standard NSAIDs. Think about that. The little pill in the jar by your bed might be fighting inflammation as hard as the stuff you need a prescription for.
“Melatonin is already in people’s homes, it’s inexpensive, and we know it’s safe,” says Wu.
Safety is relative. It’s generally fine for short-term use if you aren’t pregnant. Long term? The data is thin. Side effects do exist—nausea, dizziness, headaches. Real enough to notice. Annoying enough to stop some people. But compared to the baggage carried by heavy-duty painkillers, melatonin is light.
Not everyone felt it, though. If the pain came from surgery, melatonin didn’t do much. No statistically significant change there. It really helped the people stuck with long-term, chronic MSK pain. That’s the crowd. That’s who this is for.
Why? Maybe the antioxidant effect. Melatonin clears out cell stress and knocks back inflammation. Or maybe it’s just sleep. Deep, real rest lets muscles relax. Pain often spikes when the body is tired and tense. Fix the sleep, maybe you fix the pain. Which one causes which? Who knows yet.
Researchers aren’t telling you to throw away your meds.
“Instead, after consultation with a doctor,” Wu explains, “it may be used as an adjunct to existing treatments.”
Add it on top. Don’t swap it out blindly. Co-author Paulo Ferreira notes they are applying a known drug to a problem affecting millions. It’s practical. It’s accessible. But pain is weird. It’s tangled up in psychology and social layers. A supplement might help one person and do nothing for their neighbor.
We still have holes to fill in the research. Bigger groups. More time. We need to understand the how, not just the what. For now, though, it’s an interesting twist on a familiar molecule. Two birds, one stone?
Maybe. For a lucky few, certainly.
Even that counts.
The findings live in the journal Pain. 🛌💊
